eNauka - pregled
Pregled prema Autor Schenker, Michael
Prikaz rezultata 1 do 4 od 4
| Godina | Naslov | Autor(i) | Tip rezultata | Mp-kat. |
|---|---|---|---|---|
| 2018 | Afatinib in chemotherapy pre-treated EGFR mutation-positive NSCLC | Thongprasert, Sumitra; Geater, SL; Clement, D; Abdelaziz, A; Reyes-Igama, J; Jovanovic, D; Alexandru, A; Schenker, Michael; Sriuranpong, Virote; Serwatowski, P;
Suresh, S; Cseh, Agnieszka; Gaafar, Rabab;
| Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
| 2019 | Afatinib in locally advanced/metastatic NSCLC harboring common EGFR</i> mutations, after chemotherapy: a Phase IV study | Thongprasert, Sumitra; Geater, Sarayut L; Clement, Dana; Abdelaziz, Amr; Reyes-Igama, Jasmin; Jovanovic, Dragana; Alexandru, Aurelia; Schenker, Michael; Sriuranpong, Virote; Serwatowski, Piotr;
Suresh, Sheethal; Cseh, Agnieszka; Gaafar, Rabab;
| Naučni članak | Mp kategorija će biti prikazana naknadno. |
| 2017 | Phase 3 Study of Ganetespib, a Heat Shock Protein 90 Inhibitor, with Docetaxel versus Docetaxel in Advanced Non-Small Cell Lung Cancer (GALAXY-2) | Pillai, Rathi N; Fennell, Dean; Kovcin, Vladimir N; Ciuleanu, Tudor E; Ramlau, Rodryg; Kowalski, Dariusz; Schenker, Michael; Perin, Branislav M; Yalcin, Ilker; Teofilovici, Florentina;
Vukovic, Vojo M; Ramalingam, Suresh S;
| Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
| 2020 | Randomized Phase III Study of Ganetespib, a Heat Shock Protein 90 Inhibitor, With Docetaxel Versus Docetaxel in Advanced Non?Small-Cell Lung Cancer (GALAXY-2) | Pillai, Rathi N; Fennell, Dean A; Kovcin, Vladimir N; Ciuleanu, Tudor E; Ramlau, Rodryg; Kowalski, Dariusz; Schenker, Michael; Yalcin, Ilker; Teofilovici, Florentina; Vukovic, Vojo M;
Ramalingam, Suresh S;
| Naučni članak | 21a+M21a+ - Vodeći međunarodni časopis kategorije M21a+ |